По вашему запросу найдено документов: 783

Страница 1 из 79

studies in this field have shown that topoisomerases I and II are one of the main molecular targets

topoisomerase I and II was studied. Resorting to the data of molecular docking, a probable mechanism

activity against topoisomerases I and IIα, key cell cycle enzymes. Using flow cytometry, muricadienin

infarction in order to facilitate the development of novel therapy. Inhibitor of apoptosis

-nities for developing novel promising inhibitors of TYMS.

on the activity of hydrolytic enzymes (amylases and proteinases) and their protein inhibitors in the leaves

Опыт таргетной терапии ALK-позитивного немелкоклеточного рака легкого: клинический случайALK inhibitors

Механизм работы разных поколений ингибиторов EGFR при злокачественных опухолях легких. Обзор литературы и обобщение данныхThe mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors

РЕЗИСТЕНТНОСТЬ К ИНГИБИТОРАМ КОНТРОЛЬНЫХ ТОЧЕК ИММУНИТЕТА В ЛЕЧЕНИИ МЕТАСТАТИЧЕСКОГО РАКА ПОЧКИRESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF METASTATIC RENAL CANCER

inhibitors (ICI) still have limited therapeutic efficacy. A growing number of investigations has demonstrated

Страница 1 из 79